Positives

• One patient with severe orthostatic hypotension after concussion trauma described droxidopa as a life changer, saying they no longer pass out on standing even though they still feel dizzy in the first 20 seconds WebMD.
• A patient with adrenal damage from chemotherapy said they felt wonderful with noticeably more energy after about two weeks on Northera WebMD.

Negatives

• Despite symptom-frequency reductions, droxidopa appears to have only diminutive impact on POTS quality-of-life scores and blood pressure, and larger trials are still needed to confirm meaningful day-to-day functional benefit PubMed.
  
  

Hurdles & Side Effects

• Northera is FDA-approved for neurogenic orthostatic hypotension only, so POTS use is off-label and insurance authorization is difficult; cash price runs roughly $4,000-$5,000 per month at retail QuickRx.
  
  
• The drug carries a boxed warning for supine hypertension; patients must elevate their head while sleeping and avoid late-evening doses, which complicates the practical regimen for younger POTS patients Northera.